open access

Vol 91, No 6 (2020)
ORIGINAL PAPERS Gynecology
Published online: 2020-06-30
Get Citation

The pain symptoms and mass recurrence rates after ovarian cystectomy or uni/bilateral oophorectomy procedures in patients over 40 years old with endometriosis

Sukru Yildiz, Cihan Kaya, Ismail Alay, Huseyin Cengiz, Murat Ekin, Levent Yasar
DOI: 10.5603/GP.2020.0053
·
Pubmed: 32627149
·
Ginekol Pol 2020;91(6):295-300.

open access

Vol 91, No 6 (2020)
ORIGINAL PAPERS Gynecology
Published online: 2020-06-30

Abstract

Objectives: To evaluate the rates of pain and mass recurrence of the patients over 40 years old with endometriosis who underwent ovarian cystectomy or uni/bilateral oophorectomy. Material and methods: A retrospective study was conducted with 98 patients undergoing laparoscopic surgery for endometriosis in a tertiary referral center between the time period July 2015 and July 2019. All the patients followed every 3 months and requested to fill the Visual Analogue Scale (VAS) for evaluation of pelvic pain and an ultrasound scan was performed. The inclusion criteria for this study were as follows, patients with ages over 40, with regular menstrual periods, and who denied hysterectomy and any postoperative hormonal medical treatments. Results: When the groups were compared in terms of age, body mass index, cyst diameter, CA-125 serum concentrations, preoperative and after surgical pelvic pain scores, mean follow up periods, postoperative hospital stay. However, each of the mean numbers of gravidity and parity were significantly higher than bilateral salpingo-oophorectomy (BSO) groups compared to the other groups (p = 0.04 and p = 0.03, respectively). The laterality, the recurrence rates, and the type of recurrence did not have a significant effect in the group comparison. Conclusions: The ovarian tissue preserving procedures could be offered for the women over 40 years old suffering from endometriosis with no significant increase in pain symptom or mass recurrence rates considering beneficial effects of estrogen on cardiovascular system, vasomotor symptoms, and bone mineral density.

Abstract

Objectives: To evaluate the rates of pain and mass recurrence of the patients over 40 years old with endometriosis who underwent ovarian cystectomy or uni/bilateral oophorectomy. Material and methods: A retrospective study was conducted with 98 patients undergoing laparoscopic surgery for endometriosis in a tertiary referral center between the time period July 2015 and July 2019. All the patients followed every 3 months and requested to fill the Visual Analogue Scale (VAS) for evaluation of pelvic pain and an ultrasound scan was performed. The inclusion criteria for this study were as follows, patients with ages over 40, with regular menstrual periods, and who denied hysterectomy and any postoperative hormonal medical treatments. Results: When the groups were compared in terms of age, body mass index, cyst diameter, CA-125 serum concentrations, preoperative and after surgical pelvic pain scores, mean follow up periods, postoperative hospital stay. However, each of the mean numbers of gravidity and parity were significantly higher than bilateral salpingo-oophorectomy (BSO) groups compared to the other groups (p = 0.04 and p = 0.03, respectively). The laterality, the recurrence rates, and the type of recurrence did not have a significant effect in the group comparison. Conclusions: The ovarian tissue preserving procedures could be offered for the women over 40 years old suffering from endometriosis with no significant increase in pain symptom or mass recurrence rates considering beneficial effects of estrogen on cardiovascular system, vasomotor symptoms, and bone mineral density.

Get Citation

Keywords

endometriosis; pain symptom; recurrence; oophorectomy

About this article
Title

The pain symptoms and mass recurrence rates after ovarian cystectomy or uni/bilateral oophorectomy procedures in patients over 40 years old with endometriosis

Journal

Ginekologia Polska

Issue

Vol 91, No 6 (2020)

Pages

295-300

Published online

2020-06-30

DOI

10.5603/GP.2020.0053

Pubmed

32627149

Bibliographic record

Ginekol Pol 2020;91(6):295-300.

Keywords

endometriosis
pain symptom
recurrence
oophorectomy

Authors

Sukru Yildiz
Cihan Kaya
Ismail Alay
Huseyin Cengiz
Murat Ekin
Levent Yasar

References (34)
  1. Busacca M, Vignali M. Ovarian endometriosis: from pathogenesis to surgical treatment. Curr Opin Obstet Gynecol. 2003; 15(4): 321–326.
  2. Chapron C, Vercellini P, Barakat H, et al. Management of ovarian endometriomas. Hum Reprod Update. 2002; 8(6): 591–597.
  3. Hart RJ, Hickey M, Maouris P, et al. Excisional surgery versus ablative surgery for ovarian endometriomata. Cochrane Database Syst Rev. 2005(3): CD004992.
  4. Busacca M, Marana R, Caruana P, et al. Recurrence of ovarian endometrioma after laparoscopic excision. American Journal of Obstetrics and Gynecology. 1999; 180(3): 519–523.
  5. Canis M, Bourdel N, Houlle C, et al. Endometriosis may not be a chronic disease: an alternative theory offering more optimistic prospects for our patients. Fertil Steril. 2016; 105(1): 32–34.
  6. Kikuchi I, Takeuchi H, Kitade M, et al. Recurrence rate of endometriomas following a laparoscopic cystectomy. Acta Obstet Gynecol Scand. 2006; 85(9): 1120–1124.
  7. He ZX, Sun TT, Wang S, et al. Risk Factors for Recurrence of Ovarian Endometriosis in Chinese Patients Aged 45 and Over. Chin Med J (Engl). 2018; 131(11): 1308–1313.
  8. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertility and Sterility. 1997; 67(5): 817–821.
  9. Mais V, Guerriero S, Ajossa S, et al. The efficiency of transvaginal ultrasonography in the diagnosis of endometrioma. Fertility and Sterility. 1993; 60(5): 776–780.
  10. Kennedy S, Bergqvist A, Chapron C, et al. ESHRE Special Interest Group for Endometriosis and Endometrium Guideline Development Group. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod. 2005; 20(10): 2698–2704.
  11. Morgante G, Ditto A, La Marca A, et al. Low-dose danazol after combined surgical and medical therapy reduces the incidence of pelvic pain in women with moderate and severe endometriosis. Hum Reprod. 1999; 14(9): 2371–2374.
  12. Vignali M, Bianchi S, Candiani M, et al. Surgical treatment of deep endometriosis and risk of recurrence. J Minim Invasive Gynecol. 2005; 12(6): 508–513.
  13. Liu X, Yuan L, Shen F, et al. Patterns of and risk factors for recurrence in women with ovarian endometriomas. Obstet Gynecol. 2007; 109(6): 1411–1420.
  14. Li Hj, Leng Jh, Lang Jh, et al. [Correlative factors analysis of recurrence of endometriosis after conservative surgery]. Zhonghua Fu Chan Ke Za Zhi. 2005; 40(1): 13–16.
  15. Ouchi N, Akira S, Mine K, et al. Recurrence of ovarian endometrioma after laparoscopic excision: risk factors and prevention. J Obstet Gynaecol Res. 2014; 40(1): 230–236.
  16. Sengoku K, Miyamoto T, Horikawa M, et al. Clinicopathologic risk factors for recurrence of ovarian endometrioma following laparoscopic cystectomy. Acta Obstet Gynecol Scand. 2013; 92(3): 278–284.
  17. Vercellini P, Somigliana E, Vigano P, et al. 'Blood On The Tracks' from corpora lutea to endometriomas. BJOG. 2009; 116(3): 366–371.
  18. Witt BR, Barad DH. Management of endometriosis in women elder than 40 years of age. Obstet Gynecol Clin North Am. 1993; 20(2): 349–363.
  19. Hou H, Zhao Z, Machuki JO, et al. Estrogen deficiency compromised the βAR-Gs/Gi coupling: implications for arrhythmia and cardiac injury. Pflugers Arch. 2018; 470(3): 559–570.
  20. Vercellini P, Viganò P, Buggio L, et al. Perimenopausal management of ovarian endometriosis and associated cancer risk: When is medical or surgical treatment indicated? Best Pract Res Clin Obstet Gynaecol. 2018; 51: 151–168.
  21. Sesti F, Capozzolo T, Pietropolli A, et al. Recurrence rate of endometrioma after laparoscopic cystectomy: a comparative randomized trial between post-operative hormonal suppression treatment or dietary therapy vs. placebo. Eur J Obstet Gynecol Reprod Biol. 2009; 147(1): 72–77.
  22. Chon SJ, Lee SH, Choi JH, et al. Preoperative risk factors in recurrent endometrioma after primary conservative surgery. Obstet Gynecol Sci. 2016; 59(4): 286–294.
  23. Selcuk S, Cam C, Koc N, et al. Evaluation of risk factors for the recurrence of ovarian endometriomas. Eur J Obstet Gynecol Reprod Biol. 2016; 203: 56–60.
  24. Guzel AI, Topcu HO, Ekilinc S, et al. Recurrence factors in women underwent laparoscopic surgery for endometrioma. Minerva Chir. 2014; 69(5): 277–282.
  25. Campo S, Campo V, Gambadauro P. Is a positive family history of endometriosis a risk factor for endometrioma recurrence after laparoscopic surgery? Reprod Sci. 2014; 21(4): 526–531.
  26. Kim ML, Kim JM, Seong SJu, et al. Recurrence of ovarian endometrioma after second-line, conservative, laparoscopic cyst enucleation. Am J Obstet Gynecol. 2014; 210(3): 216.e1–216.e6.
  27. Yang XH, Ai XZ, Ding Y. The research progression of the related factor for endometriosis recurrence. Chin Obstet Gynecol. 2012; 39: 437–445.
  28. Dunselman GAJ, Vermeulen N, Becker C, et al. European Society of Human Reproduction and Embryology. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014; 29(3): 400–412.
  29. Leyland N, Casper R, Laberge P, et al. Endometriosis: Diagnosis and Management. J Obstet Gynaecol Can. 2010; 32(7): 51–53.
  30. National Institute for Health and Care Exellence. Endometriosis diagnosis and management (NICE guideline 73). 2017.
  31. Exacoustos C, Zupi E, Amadio A, et al. Recurrence of endometriomas after laparoscopic removal: sonographic and clinical follow-up and indication for second surgery. J Minim Invasive Gynecol. 2006; 13(4): 281–288.
  32. Alio L, Angioni S, Arena S, et al. Endometriosis: seeking optimal management in women approaching menopause. Climacteric. 2019; 22(4): 329–338.
  33. Vercellini P, Crosignani PG, Fadini R, et al. A gonadotrophin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis. Br J Obstet Gynaecol. 1999; 106(7): 672–677.
  34. Oral E, Aydin O, Kumbak BA, et al. Concomitant endometriosis in malignant and borderline ovarian tumours. J Obstet Gynaecol. 2018; 38(8): 1104–1109.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl